Chronic Heart Failure in Children: State of the Art and New Perspectives

Pediatric heart failure (HF) is an important clinical condition with high morbidity and mortality. Compared to adults, pediatric HF shows different etiologies characterized by different physiology, a different clinical course, and deeply different therapeutic approaches. In the last few years, new drugs have been developed and new therapeutic strategies have been proposed with the goal of identifying an individualized treatment regimen. The aim of this article is to review the new potential drugs and non-pharmacological therapies for pediatric heart failure in children.

Automated summary

Pediatric heart failure is a clinically important condition with high morbidity and mortality. It differs from adult heart failure in terms of etiology, physiology, clinical course, and therapeutic approaches. New drugs and non-pharmacological therapies have been developed to identify personalized treatment regimens. This article reviews the potential new drugs and non-pharmacological therapies for pediatric heart failure.